期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (4)
Hepatocellular carcinoma (HCC), the sixth most common cancer worldwide, has an incidence rate equal to mortality. Over 80% of HCC cases occur within a......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (6)
Transforming growth factor beta (TGF-beta) signaling in hepatocytes promotes steatosis and body weight gain. However, processes that TGF-beta signalin......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (7)
Accurate prediction of the extent of fibrosis is of great clinical importance in patients infected with chronic hepatitis B (CHB). This study aimed to......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (9)
Metabolic-associated fatty liver disease (MAFLD) is a series of liver diseases based on liver steatosis and metabolic disorders. Steatosis, as the cor......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (7)
Primary liver tumors (PLCs) and liver metastasis currently represent the leading cause of cancer-related deaths worldwide due to poor outcomes, high i......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (8)
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies; its recurrence is associated with high mortality and poor recurrence-free su......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (3)
It is essential to determine contributors around impairment in health-related quality of life (HRQoL) in patients with cirrhosis aiming at improving h......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (8)
Diet is reported to be associated with hepatocellular carcinoma (HCC), but whether there is a causal relationship remains unclear. This study aimed to......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (7)
The limited performance of guideline-recommended abdominal ultrasound and serum alpha-fetoprotein (AFP) highlights the urgent, unmet need for new biom......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (10)
Both iron overload and iron deficiency have been reported in obesity and metabolic syndromes. Due to the presence of multiple intracellular iron pools......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (12)
Fenofibrate (FF) has shown potential benefits in patients with primary biliary cholangitis (PBC) who have an incomplete response to ursodeoxycholic ac......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (12)
The ability to determine the prognosis of lean nonalcoholic fatty liver disease (NAFLD) is essential for decision making in clinical settings. Using a......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (10)
It is interesting that high iron is an independent inducer or cofactor of hepatocellular carcinoma (HCC) while the amount of iron is decreased in the ......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (9)
The appropriate prophylaxis for hepatitis B virus reactivation (HBVr) during gestation for immunocompromised pregnant women has yet to be determined. ......
期刊： HEPATOLOGY COMMUNICATIONS, 2022; 6 (12)
CircRNAs have been reported to play crucial roles in tumor progression and recurrence, showing potential as biomarkers in cancer. However, the global ......
